deltatrials
Completed PHASE4 NCT00609388

Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation

Evaluation of Tacrolimus (Prograf®) Intraportal Infusion During the Implantation and the Protective Effect on Ischemia-reperfusion Injury in Orthotopic Liver Transplant Recipients - Single Center Study

Sponsor: Medical University of Vienna

Conditions Ischemia Reperfusion Injury
Interventions Saline solution 0.9% (250mL) Tacrolimus
Updated 5 times since 2017 Last updated: Dec 7, 2010 Started: Jan 31, 2008 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

A PHASE4 clinical study on Ischemia Reperfusion Injury, this trial is completed. The trial is conducted by Medical University of Vienna and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University of Vienna
Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Vienna, Austria